Twenty-Four-Month Effectiveness of Guanfacine Extended Release in Children and Adolescents Aged 6 to 17 Years with Attention-Deficit/Hyperactivity Disorder

被引：0
|
作者：
Sallee, Floyd [1 ]
McBurnett, Keith [2 ]
Wigal, Timothy [3 ]
Lyne, Andrew [4 ]
Youcha, Sharon [5 ]
Rubin, Jonathan [5 ]
机构：
[1] Univ Cincinnati, Dept Psychiat, Cincinnati, OH USA
[2] Univ Calif San Francisco, Dept Psychiat, San Francisco, CA 94143 USA
[3] Univ Calif Irvine, Dept Pediat, Irvine Child Dev Ctr, Irvine, CA 92717 USA
[4] Shire Pharmaceut Dev Ltd, Global Biometr, Basingstoke, Hants, England
[5] Shire Dev Inc, Global Med Affairs, Wayne, PA USA
来源：
BIOLOGICAL PSYCHIATRY | 2010年 / 67卷 / 09期
关键词：
D O I：
暂无
中图分类号：
Q189 [神经科学];
学科分类号：
071006 ;
摘要：
758
引用
收藏
页码：217S / 218S
页数：2
相关论文
共 50 条
  • [21] Long-term safety and efficacy of guanfacine extended release in children and adolescents with Attention-Deficit/Hyperactivity disorder
    Sallee, Floyd
    McGough, James J.
    Wigall, Timothy
    Farrand, Kimberly
    Lyne, Andrew
    Biederman, Joseph
    BIOLOGICAL PSYCHIATRY, 2008, 63 (07) : 247S - 247S
  • [22] Guanfacine extended release for children and adolescents with attention-deficit/hyperactivity disorder: efficacy following prior methylphenidate treatment
    Huss, Michael
    Sikirica, Vanja
    Hervas, Amaia
    Newcorn, Jeffrey H.
    Harpin, Valerie
    Robertson, Brigitte
    NEUROPSYCHIATRIC DISEASE AND TREATMENT, 2016, 12 : 1085 - 1101
  • [23] COST-EFFECTIVENESS OF GUANFACINE EXTENDED-RELEASE VERSUS ATOMOXETINE FOR THE TREATMENT OF CHILDREN AND ADOLESCENTS WITH ATTENTION-DEFICIT/HYPERACTIVITY DISORDER IN CANADA
    Lachaine, J.
    Sikirica, V
    Mathurin, K.
    VALUE IN HEALTH, 2014, 17 (03) : A213 - A214
  • [24] Extended-release medications for children and adolescents with attention-deficit hyperactivity disorder
    Feldman, M.
    Belanger, S.
    PAEDIATRICS & CHILD HEALTH, 2009, 14 (09) : 593 - 596
  • [25] Guanfacine Extended Release Adjunctive to a Psychostimulant in the Treatment of Comorbid Oppositional Symptoms in Children and Adolescents with Attention-Deficit/Hyperactivity Disorder
    Findling, Robert L.
    McBurnett, Keith
    White, Carla
    Youcha, Sharon
    JOURNAL OF CHILD AND ADOLESCENT PSYCHOPHARMACOLOGY, 2014, 24 (05) : 245 - 252
  • [26] A Randomized, Placebo-Controlled Trial of Guanfacine Extended Release in Adolescents With Attention-Deficit/Hyperactivity Disorder
    Wilens, Timothy E.
    Robertson, Brigitte
    Sikirica, Vanja
    Harper, Linda
    Young, Joel L.
    Bloomfield, Ralph
    Lyne, Andrew
    Rynkowski, Gail
    Cutler, Andrew J.
    JOURNAL OF THE AMERICAN ACADEMY OF CHILD AND ADOLESCENT PSYCHIATRY, 2015, 54 (11): : 916 - 925
  • [27] THE COST-EFFECTIVENESS OF GUANFACINE EXTENDED RELEASE (GXR) VERSUS ATOMOXETINE (ATX) FOR THE TREATMENT OF ATTENTION-DEFICIT/HYPERACTIVITY DISORDER (ADHD) IN CHILDREN AND ADOLESCENTS
    Erder, M.
    Chen, K.
    Wu, E. Q.
    Hodgkins, P.
    Sikirica, V
    VALUE IN HEALTH, 2011, 14 (03) : A192 - A192
  • [28] Cost Effectiveness of Guanfacine Extended-Release versus Atomoxetine for the Treatment of Attention-Deficit/Hyperactivity Disorder
    Erder, M.
    Xie, Jipan
    Signorovitch, James
    Chen, Kristina
    Hodgkins, Paul
    Lu, Mei
    Wu, Eric
    Sikirica, Vanja
    APPLIED HEALTH ECONOMICS AND HEALTH POLICY, 2012, 10 (06) : 381 - 395
  • [29] Cost effectiveness of guanfacine extended release as an adjunctive therapy to a stimulant compared with stimulant monotherapy for the treatment of attention-deficit hyperactivity disorder in children and adolescents
    Sikirica V.
    Haim Erder M.
    Xie J.
    MacAulay D.
    Diener M.
    Hodgkins P.
    Wu E.Q.
    PharmacoEconomics, 2012, 30 (8) : e1 - e15
  • [30] Effects of Guanfacine Extended Release on Secondary Measures in Children With Attention-Deficit/Hyperactivity Disorder and Oppositional Symptoms
    Sallee, Floyd
    Spencer, Thomas
    Connor, Daniel
    Lopez, Frank
    Lyne, Andrew
    Tremblay, Gerald
    BIOLOGICAL PSYCHIATRY, 2009, 65 (08) : 149S - 149S
12345